ArticleThe Journal of clinical investigation2018

Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma.

Reinaldo Franqui-Machin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.